The silent exclusion: rethinking eligibility and generalizability in clinical trials.
作者信息
Jensen Jens-Ulrik, Johansen Niklas Dyrby, Mathioudakis Alexander G, Biering-Sørensen Tor, Sivapalan Pradeesh
机构信息
Copenhagen Respiratory Research, Department of Medicine, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
出版信息
Lancet Reg Health West Pac. 2025 Jun 14;61:101605. doi: 10.1016/j.lanwpc.2025.101605. eCollection 2025 Aug.
Abstract
摘要
相似文献
1
The silent exclusion: rethinking eligibility and generalizability in clinical trials.沉默的排除：重新思考临床试验的资格标准和可推广性
Lancet Reg Health West Pac. 2025 Jun 14;61:101605. doi: 10.1016/j.lanwpc.2025.101605. eCollection 2025 Aug.
2
Eligibility Criteria of Randomized Clinical Trials in Critical Care Medicine.重症医学随机临床试验的纳入标准。
JAMA Netw Open. 2025 Jan 2;8(1):e2454944. doi: 10.1001/jamanetworkopen.2024.54944.
3
Clinical Trials Studying Suicide Risk Reduction: Who is Excluded From Participation.研究降低自杀风险的临床试验：哪些人被排除在参与之外。
Arch Suicide Res. 2025 Jan-Mar;29(1):77-90. doi: 10.1080/13811118.2024.2322128. Epub 2024 Feb 28.
4
Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria.阿片类药物替代和拮抗剂治疗试验排除了常见的成瘾患者：对纳入标准的系统评价和分析
Trials. 2015 Oct 21;16:475. doi: 10.1186/s13063-015-0942-4.
5
Silent protocol modifications in multiple sclerosis clinical trials: a registry-based cross-sectional study.多发性硬化症临床试验中的静默方案修改：一项基于登记处的横断面研究。
Ther Adv Neurol Disord. 2025 Jun 30;18:17562864251335247. doi: 10.1177/17562864251335247. eCollection 2025.
6
Gynecologic cancer clinical trial eligibility criteria as a marker for equitable clinical trial access.妇科癌症临床试验资格标准作为公平获得临床试验机会的一个指标。
J Natl Cancer Inst. 2025 May 1;117(5):980-988. doi: 10.1093/jnci/djae338.
7
Eligibility criteria in knee osteoarthritis clinical trials: systematic review.膝关节骨关节炎临床试验的纳入标准：系统评价。
Clin Rheumatol. 2013 Nov;32(11):1569-74. doi: 10.1007/s10067-013-2342-z. Epub 2013 Jul 23.
8
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.镰状细胞病患者无症状性脑梗死的预防干预措施。
Cochrane Database Syst Rev. 2017 May 13;5(5):CD012389. doi: 10.1002/14651858.CD012389.pub2.
9
Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009-2023).导致美国食品药品监督管理局药物批准的癌症临床试验中的性能状态资格要求和入组特征（2009 - 2023年）
Eur J Cancer. 2025 Jul 25;225:115589. doi: 10.1016/j.ejca.2025.115589. Epub 2025 Jun 26.
10
Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: A systematic review on varenicline.选择标准对不同临床试验和实验室研究中吸烟药物治疗研究的普遍性限制不同：一项关于伐尼克兰的系统评价
Drug Alcohol Depend. 2016 Dec 1;169:180-189. doi: 10.1016/j.drugalcdep.2016.10.018. Epub 2016 Oct 22.
本文引用的文献
1
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.针对嗜酸性粒细胞计数提示 2 型炎症的 COPD，应用度普利尤单抗。
N Engl J Med. 2023 Jul 20;389(3):205-214. doi: 10.1056/NEJMoa2303951. Epub 2023 May 21.
2
Waivers of informed consent in research with competent participants and the Declaration of Helsinki.针对有行为能力参与者的研究中的知情同意书豁免与《赫尔辛基宣言》
Eur J Clin Pharmacol. 2023 Apr;79(4):575-578. doi: 10.1007/s00228-023-03472-w. Epub 2023 Mar 8.
3
Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial.在基于实用登记处的环境中将65至79岁丹麦公民随机分为高剂量四价流感疫苗组和标准剂量四价流感疫苗组的可行性：DANFLU-1试验的原理与设计
Pilot Feasibility Stud. 2022 Apr 21;8(1):87. doi: 10.1186/s40814-022-01044-w.
4
Improving the external validity of clinical trials: the case of multiple chronic conditions.提高临床试验的外部有效性：以多种慢性病为例。
J Comorb. 2013 Dec 24;3(Spec Issue):30-35. doi: 10.15256/joc.2013.3.27. eCollection 2013.
5
Reporting of pre-enrolment screening with randomized clinical trials: A small item that could impact a big difference.随机临床试验中入组前筛查的报告：一个可能产生重大影响的小项目。
Perspect Clin Res. 2015 Jul-Sep;6(3):139-43. doi: 10.4103/2229-3485.159937.
6
Underrepresentation of women, elderly patients, and racial minorities in the randomized trials used for cardiovascular guidelines.在用于制定心血管疾病指南的随机试验中，女性、老年患者和少数族裔的代表性不足。
JAMA Intern Med. 2014 Nov;174(11):1868-70. doi: 10.1001/jamainternmed.2014.4758.
7
STREPTOMYCIN treatment of pulmonary tuberculosis.链霉素治疗肺结核。
Br Med J. 1948 Oct 30;2(4582):769-82.
8
Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review.发表于高影响力综合医学期刊的随机对照试验的纳入标准：一项系统抽样综述
JAMA. 2007 Mar 21;297(11):1233-40. doi: 10.1001/jama.297.11.1233.
9
External validity of randomised controlled trials: "to whom do the results of this trial apply?".随机对照试验的外部效度：“该试验结果适用于谁？”
Lancet. 2005;365(9453):82-93. doi: 10.1016/S0140-6736(04)17670-8.
10
Representation of the elderly, women, and minorities in heart failure clinical trials.老年患者、女性和少数族裔在心力衰竭临床试验中的代表性。
Arch Intern Med. 2002;162(15):1682-8. doi: 10.1001/archinte.162.15.1682.
Zotero 插件